Search - tctmd.com

Displaying 21 - 37 of 37

Sort: Relevancy | Date

News Conference News TCT 2020

No Reperfusion Benefit From Crushed Prasugrel Prior to PCI: COMPARE CRUSH

L.A. McKeown

October 14, 2020

News Daily News

Diabetes Influences Relative Effects of Ticagrelor, Prasugrel in ACS: ISAR-REACT 5

Todd Neale

October 09, 2020

News Daily News

Features of Complex CAD Carry Progressive Risk in PCI, Registry Confirms

Caitlin E. Cox

October 08, 2020

News Daily News

PCI Volumes Rise in US and Japan, but for Different Reasons

Michael O'Riordan

September 14, 2020

News Daily News

LDL Cholesterol Control Post-PCI Is Low and Linked to Worse Outcomes

Yael L. Maxwell

September 14, 2020

News Daily News

Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI

L.A. McKeown

August 10, 2020

News Conference News EuroPCR 2020

Tirofiban Provides Better Platelet Inhibition Than Cangrelor in STEMI Patients

Michael O'Riordan

June 30, 2020

News Conference News TVT 2020

Antithrombotics After PFO Closure: Much to Discuss, Little Data to Inform

Yael L. Maxwell

June 26, 2020

News Opinion Conversations in Cardiology

Conversations in Cardiology: Uncovered Struts on OCT After 12 Years?

March 27, 2020

News Daily News

Bioprosthetic Valve Thrombosis Rare but Not Benign: New Insights

Yael L. Maxwell

February 28, 2020

News Daily News

Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis

Michael O'Riordan

February 10, 2020

News Conference News AHA 2019

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

Shelley Wood

November 11, 2019

News Daily News

Women More Likely Than Men to Develop Heart Failure After STEMI

L.A. McKeown

November 04, 2019

News Daily News

Morphine Not Linked to Increased Short-term Mortality in STEMI: Meta-analysis

L.A. McKeown

November 01, 2019

News Conference News ESC 2019

For A-fib/PCI Combo, Edoxaban Matches VKA but Not Superior: ENTRUST-AF PCI

Todd Neale

September 03, 2019

News Conference News ESC 2019

COMPLETE Beats Culprit-Only PCI in Multivessel STEMI and Timing Doesn’t Matter

Yael L. Maxwell

September 01, 2019

News Conference News ACC 2019

First Ticagrelor Reversal Agent Shows Quick Onset, Long Duration in Early Results

Yael L. Maxwell

March 25, 2019

Advertisement

No Reperfusion Benefit From Crushed Prasugrel Prior to PCI: COMPARE CRUSH

Diabetes Influences Relative Effects of Ticagrelor, Prasugrel in ACS: ISAR-REACT 5

Features of Complex CAD Carry Progressive Risk in PCI, Registry Confirms

PCI Volumes Rise in US and Japan, but for Different Reasons

LDL Cholesterol Control Post-PCI Is Low and Linked to Worse Outcomes

Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI

Tirofiban Provides Better Platelet Inhibition Than Cangrelor in STEMI Patients

Antithrombotics After PFO Closure: Much to Discuss, Little Data to Inform

Conversations in Cardiology: Uncovered Struts on OCT After 12 Years?

Bioprosthetic Valve Thrombosis Rare but Not Benign: New Insights

Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

Women More Likely Than Men to Develop Heart Failure After STEMI

Morphine Not Linked to Increased Short-term Mortality in STEMI: Meta-analysis

For A-fib/PCI Combo, Edoxaban Matches VKA but Not Superior: ENTRUST-AF PCI

COMPLETE Beats Culprit-Only PCI in Multivessel STEMI and Timing Doesn’t Matter

First Ticagrelor Reversal Agent Shows Quick Onset, Long Duration in Early Results

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content